We consider this will be an important issue in future study for evaluating the effect of metastatic tumour cells on expression and secretion activity of endogenous anticancer factors, specifically IL-25 (ref. 9), in the tumour microenvironment. The gene discussed is IL25; the disease is neoplasm.